Randall Kaye - Net Worth and Insider Trading
Randall Kaye Net Worth
The estimated net worth of Randall Kaye is at least $440,208 dollars as of 2024-04-24. Randall Kaye is the Chief Medical Officer of Axsome Therapeutics Inc and owns about 6,022 shares of Axsome Therapeutics Inc (AXSM) stock worth over $440,208. Details can be seen in Randall Kaye's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Randall Kaye has not made any transactions after 2015-12-23 and currently still holds the listed stock(s).
Transaction Summary of Randall Kaye
Randall Kaye Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Randall Kaye owns 2 companies in total, including Axsome Therapeutics Inc (AXSM) , and Longboard Pharmaceuticals Inc (LBPH) .
Click here to see the complete history of Randall Kaye’s form 4 insider trades.
Insider Ownership Summary of Randall Kaye
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AXSM | Axsome Therapeutics Inc | 2015-12-23 | Chief Medical Officer |
| LBPH | Longboard Pharmaceuticals Inc | 2022-03-21 | CMO |
Randall Kaye Latest Holdings Summary
Randall Kaye currently owns a total of 1 stock. Randall Kaye owns 6,022 shares of Axsome Therapeutics Inc (AXSM) as of December 23, 2015, with a value of $440,208.
Latest Holdings of Randall Kaye
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AXSM | Axsome Therapeutics Inc | 2015-12-23 | 6,022 | 73.10 | 440,208 |
Holding Weightings of Randall Kaye
Randall Kaye Form 4 Trading Tracker
According to the SEC Form 4 filings, Randall Kaye has made a total of 0 transactions in Axsome Therapeutics Inc (AXSM) over the past 5 years. The most-recent trade in Axsome Therapeutics Inc is the acquisition of 1,000 shares on December 23, 2015, which cost Randall Kaye around $9,030.
Insider Trading History of Randall Kaye
- 1
Randall Kaye Trading Performance
GuruFocus tracks the stock performance after each of Randall Kaye's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Randall Kaye is 1%. GuruFocus also compares Randall Kaye's trading performance to market benchmark return within the same time period. The performance of stocks bought by Randall Kaye within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Randall Kaye's insider trading performs compared to the benchmark.
Performance of Randall Kaye
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 39.02 | 1 | -17.39 | -23.58 | -23.64 | -37.43 |
| Relative Return to S&P 500(%) | 46.64 | 2.34 | -19.77 | -33.22 | -37.65 | -42.83 |
Randall Kaye Ownership Network
Ownership Network List of Randall Kaye
Ownership Network Relation of Randall Kaye
Randall Kaye Owned Company Details
What does Axsome Therapeutics Inc do?
Who are the key executives at Axsome Therapeutics Inc?
Randall Kaye is the Chief Medical Officer of Axsome Therapeutics Inc. Other key executives at Axsome Therapeutics Inc include Chief Operating Officer Mark L. Jacobson , General Counsel Hunter R. Murdock , and Chief Financial Officer Nick Pizzie .
Axsome Therapeutics Inc (AXSM) Insider Trades Summary
Over the past 18 months, Randall Kaye made no insider transaction in Axsome Therapeutics Inc (AXSM). Other recent insider transactions involving Axsome Therapeutics Inc (AXSM) include a net sale of 32,323 shares made by Roger Jeffs , a net sale of 29,588 shares made by Mark Coleman , and a net sale of 24,662 shares made by Mark L. Jacobson .
In summary, during the past 3 months, insiders sold 56,985 shares of Axsome Therapeutics Inc (AXSM) in total and bought 0 shares, with a net sale of 56,985 shares. During the past 18 months, 86,573 shares of Axsome Therapeutics Inc (AXSM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 86,573 shares.
Axsome Therapeutics Inc (AXSM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Axsome Therapeutics Inc Insider Transactions
Randall Kaye Mailing Address
Above is the net worth, insider trading, and ownership report for Randall Kaye. You might contact Randall Kaye via mailing address: 11388 Sorrento Valley Road, Ste. 200, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
